Triveni Meditech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 02-12-2024
- Paid Up Capital ₹ 0.10 M
as on 02-12-2024
- Company Age 12 Year, 9 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 2.42 Cr
as on 02-12-2024
- Satisfied Charges ₹ 4.65 M
as on 02-12-2024
- Revenue -8.91%
(FY 2019)
- Profit -1.11%
(FY 2019)
- Ebitda 55.21%
(FY 2019)
- Net Worth 32.97%
(FY 2019)
- Total Assets -12.89%
(FY 2019)
About Triveni Meditech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.42 Cr. The company has closed loans amounting to ₹4.65 M, as per Ministry of Corporate Affairs (MCA) records.
Sajjan Joshi and Ashok Joshi serve as directors at the Company.
- CIN/LLPIN
U33119RJ2012PTC038609
- Company No.
038609
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Apr 2012
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Triveni Meditech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sajjan Joshi  | Director | 19-Apr-2012 | Current |
| Ashok Joshi | Director | 19-Apr-2012 | Current |
Financial Performance of Triveni Meditech.
Triveni Meditech Private Limited, for the financial year ended 2019, experienced Minor drop in revenue, with a 8.91% decrease. The company also saw a slight decrease in profitability, with a 1.11% decrease in profit. The company's net worth Soared by an impressive increase of 32.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Triveni Meditech?
In 2019, Triveni Meditech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ashok Joshi And Sons Meditech Private LimitedActive 7 years 6 monthsSajjan Joshi is a mutual person
Charges (Loans)
₹24.20 M
₹4.65 M
Charges Breakdown by Lending Institutions
- City Union Bank Limited : 2.42 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jun 2020 | City Union Bank Limited | ₹4.20 M | Open |
| 27 Feb 2015 | City Union Bank Limited | ₹2.00 Cr | Open |
| 28 Mar 2014 | Dhanlaxmi Bank Limited | ₹4.65 M | Satisfied |
How Many Employees Work at Triveni Meditech?
Unlock and access historical data on people associated with Triveni Meditech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Triveni Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Triveni Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
